442 related articles for article (PubMed ID: 21776577)
1. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
[TBL] [Abstract][Full Text] [Related]
2. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
[TBL] [Abstract][Full Text] [Related]
3. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
Soen S
Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
6. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography.
Rosenberg ZS; La Rocca Vieira R; Chan SS; Babb J; Akyol Y; Rybak LD; Moore S; Bencardino JT; Peck V; Tejwani NC; Egol KA
AJR Am J Roentgenol; 2011 Oct; 197(4):954-60. PubMed ID: 21940585
[TBL] [Abstract][Full Text] [Related]
8. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
9. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Rizzoli R; Akesson K; Bouxsein M; Kanis JA; Napoli N; Papapoulos S; Reginster JY; Cooper C
Osteoporos Int; 2011 Feb; 22(2):373-90. PubMed ID: 21085935
[TBL] [Abstract][Full Text] [Related]
10. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
Wang Z; Ward MM; Chan L; Bhattacharyya T
Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
[TBL] [Abstract][Full Text] [Related]
11. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
[TBL] [Abstract][Full Text] [Related]
12. Salvage of failed osteosynthesis for an atypical subtrochanteric femoral fracture associated with long-term bisphosphonate treatment using a 95° angled blade plate.
Kim SM; Rhyu KH; Lim SJ
Bone Joint J; 2018 Nov; 100-B(11):1511-1517. PubMed ID: 30418051
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
14. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
15. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
16. Atypical fractures of the femur related to prolonged treatment with bisphosphonates for osteoporosis.
Rosenthal Y; Arami A; Kosashvili Y; Cohen N; Sidon E; Velkes S
Isr Med Assoc J; 2014 Feb; 16(2):78-82. PubMed ID: 24645224
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
[TBL] [Abstract][Full Text] [Related]
18. Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.
Warren C; Gilchrist N; Coates M; Frampton C; Helmore J; McKie J; Hooper G
ANZ J Surg; 2012 Dec; 82(12):908-12. PubMed ID: 22943522
[TBL] [Abstract][Full Text] [Related]
19. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
Nieves JW; Cosman F
Curr Osteoporos Rep; 2010 Mar; 8(1):34-9. PubMed ID: 20425089
[TBL] [Abstract][Full Text] [Related]
20. Burden of bisphosphonate-associated femoral fractures.
Shkolnikova J; Flynn J; Choong P
ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
